Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)

MeSH terms

• Acute Coronary Syndrome / complications
• Acute Coronary Syndrome / drug therapy*
• Administration, Oral
• Anticoagulants / administration & dosage*
• Atrial Fibrillation / complications
• Atrial Fibrillation / drug therapy*
• Cohort Studies
• Drug Therapy, Combination
• Fibrinolytic Agents / therapeutic use*
• Forecasting
• Humans
• Percutaneous Coronary Intervention / methods*
• Perioperative Care / methods
• Randomized Controlled Trials as Topic
• Stents
• Transcatheter Aortic Valve Replacement / methods*
• Treatment Outcome